Loading…
PRM-MS Quantitative Analysis of Isomeric N -Glycopeptides Derived from Human Serum Haptoglobin of Patients with Cirrhosis and Hepatocellular Carcinoma
Currently, surveillance strategies have inadequate performance for cirrhosis and early detection of hepatocellular carcinoma (HCC). The glycosylation of serum haptoglobin has shown to have significant differences between cirrhosis and HCC, thus can be used for diagnosis. We performed a comprehensive...
Saved in:
Published in: | Metabolites 2021-08, Vol.11 (8), p.563 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c484t-33ccc2578ee0d68ea0ee4ac0d40e5a43b1da81a634c71dd4fa579d8860ef62893 |
---|---|
cites | cdi_FETCH-LOGICAL-c484t-33ccc2578ee0d68ea0ee4ac0d40e5a43b1da81a634c71dd4fa579d8860ef62893 |
container_end_page | |
container_issue | 8 |
container_start_page | 563 |
container_title | Metabolites |
container_volume | 11 |
creator | Gutierrez Reyes, Cristian D Huang, Yifan Atashi, Mojgan Zhang, Jie Zhu, Jianhui Liu, Suyu Parikh, Neehar D Singal, Amit G Dai, Jianliang Lubman, David M Mechref, Yehia |
description | Currently, surveillance strategies have inadequate performance for cirrhosis and early detection of hepatocellular carcinoma (HCC). The glycosylation of serum haptoglobin has shown to have significant differences between cirrhosis and HCC, thus can be used for diagnosis. We performed a comprehensive liquid chromatography-parallel reaction monitoring-mass spectrometry (LC-PRM-MS) approach, where a targeted parallel reaction monitoring (PRM) strategy was coupled to a powerful LC system, to study the site-specific isomerism of haptoglobin (Hp) extracted from cirrhosis and HCC patients. We found that our strategy was able to identify a large number of isomeric
-glycopeptides, mainly located in the Hp glycosylation site Asn207. Four
-glycopeptides were found to have significant changes in abundance between cirrhosis and HCC samples (
< 0.05). Strategic combinations of the significant
-glycopeptides, either with alpha-fetoprotein (AFP) or themselves, better estimate the areas under the curve (AUC) of their respective receiver operating characteristic (ROC) curves with respect to AFP. The combination of AFP with the isomeric sialylated fucosylated
-glycopeptides Asn207 + 5-6-1-2 and Asn207 + 5-6-1-3, resulted with an AUC value of 0.98, while the AUC value for AFP alone was 0.85. When comparing cirrhosis vs. early HCC, the isomeric
-glycopeptide Asn207 + 5-6-0-1 better estimated AUC with respect to AFP (AUC
= 0.81, and AUC
+ 5-6-0-1 = 0.88, respectively). |
doi_str_mv | 10.3390/metabo11080563 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_1a88444d53054e619fedfa1abb02bb33</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_1a88444d53054e619fedfa1abb02bb33</doaj_id><sourcerecordid>2565394017</sourcerecordid><originalsourceid>FETCH-LOGICAL-c484t-33ccc2578ee0d68ea0ee4ac0d40e5a43b1da81a634c71dd4fa579d8860ef62893</originalsourceid><addsrcrecordid>eNpdkkFv0zAUgCMEYtPYlSOyxIVLhh07jnNBmgqslTYYDM7Wi_3SukriYjtF_SP8XtJ1TCu--On586f37Jdlrxm94Lym73tM0HjGqKKl5M-y06JgKme1qp8_iU-y8xjXdFqSlhVlL7MTLgSXJRWn2Z_b7zf5zR35NsKQXILktkguB-h20UXiW7KIvsfgDPlC8qtuZ_wGN8lZjOTjlN6iJW3wPZmPPQzkDsM4xbBJftn5xg17w-0kxSFF8tulFZm5EFZ-L4fBkjluIHmDXTd2EMgMgnGD7-FV9qKFLuL5w36W_fz86cdsnl9_vVrMLq9zI5RIOefGmKKsFCK1UiFQRAGGWkGxBMEbZkExkFyYilkrWiir2iolKbayUDU_yxYHr_Ww1pvgegg77cHp-4QPSw0hOdOhZqCUEMKWnJYCJatbtC0waBpaNA3nk-vDwbUZmx6tmXoO0B1Jj08Gt9JLv9VKUFopOgnePQiC_zViTLp3cf82MKAfoy5KKWohOZUT-vY_dO3HMH3bPVXyWlBWTdTFgTLBxxiwfSyGUb2fIH08QdOFN09beMT_zQv_C6qBxQo</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2565394017</pqid></control><display><type>article</type><title>PRM-MS Quantitative Analysis of Isomeric N -Glycopeptides Derived from Human Serum Haptoglobin of Patients with Cirrhosis and Hepatocellular Carcinoma</title><source>PubMed Central (Open Access)</source><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><creator>Gutierrez Reyes, Cristian D ; Huang, Yifan ; Atashi, Mojgan ; Zhang, Jie ; Zhu, Jianhui ; Liu, Suyu ; Parikh, Neehar D ; Singal, Amit G ; Dai, Jianliang ; Lubman, David M ; Mechref, Yehia</creator><creatorcontrib>Gutierrez Reyes, Cristian D ; Huang, Yifan ; Atashi, Mojgan ; Zhang, Jie ; Zhu, Jianhui ; Liu, Suyu ; Parikh, Neehar D ; Singal, Amit G ; Dai, Jianliang ; Lubman, David M ; Mechref, Yehia</creatorcontrib><description>Currently, surveillance strategies have inadequate performance for cirrhosis and early detection of hepatocellular carcinoma (HCC). The glycosylation of serum haptoglobin has shown to have significant differences between cirrhosis and HCC, thus can be used for diagnosis. We performed a comprehensive liquid chromatography-parallel reaction monitoring-mass spectrometry (LC-PRM-MS) approach, where a targeted parallel reaction monitoring (PRM) strategy was coupled to a powerful LC system, to study the site-specific isomerism of haptoglobin (Hp) extracted from cirrhosis and HCC patients. We found that our strategy was able to identify a large number of isomeric
-glycopeptides, mainly located in the Hp glycosylation site Asn207. Four
-glycopeptides were found to have significant changes in abundance between cirrhosis and HCC samples (
< 0.05). Strategic combinations of the significant
-glycopeptides, either with alpha-fetoprotein (AFP) or themselves, better estimate the areas under the curve (AUC) of their respective receiver operating characteristic (ROC) curves with respect to AFP. The combination of AFP with the isomeric sialylated fucosylated
-glycopeptides Asn207 + 5-6-1-2 and Asn207 + 5-6-1-3, resulted with an AUC value of 0.98, while the AUC value for AFP alone was 0.85. When comparing cirrhosis vs. early HCC, the isomeric
-glycopeptide Asn207 + 5-6-0-1 better estimated AUC with respect to AFP (AUC
= 0.81, and AUC
+ 5-6-0-1 = 0.88, respectively).</description><identifier>ISSN: 2218-1989</identifier><identifier>EISSN: 2218-1989</identifier><identifier>DOI: 10.3390/metabo11080563</identifier><identifier>PMID: 34436504</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Antibiotics ; Cirrhosis ; Glycopeptides ; Glycosylation ; Haptoglobin ; Hepatocellular carcinoma ; hepatocellular carcinoma (HCC) ; Liquid chromatography ; Liver cancer ; Liver cirrhosis ; Mass spectroscopy ; N-glycopeptides ; Patients ; Peptides ; PRM ; Quantitative analysis ; Retention ; Ultrasonic imaging ; α-Fetoprotein</subject><ispartof>Metabolites, 2021-08, Vol.11 (8), p.563</ispartof><rights>2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 by the authors. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c484t-33ccc2578ee0d68ea0ee4ac0d40e5a43b1da81a634c71dd4fa579d8860ef62893</citedby><cites>FETCH-LOGICAL-c484t-33ccc2578ee0d68ea0ee4ac0d40e5a43b1da81a634c71dd4fa579d8860ef62893</cites><orcidid>0000-0001-5229-4723 ; 0000-0002-6661-6073</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2565394017/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2565394017?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25752,27923,27924,37011,37012,44589,53790,53792,74897</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34436504$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gutierrez Reyes, Cristian D</creatorcontrib><creatorcontrib>Huang, Yifan</creatorcontrib><creatorcontrib>Atashi, Mojgan</creatorcontrib><creatorcontrib>Zhang, Jie</creatorcontrib><creatorcontrib>Zhu, Jianhui</creatorcontrib><creatorcontrib>Liu, Suyu</creatorcontrib><creatorcontrib>Parikh, Neehar D</creatorcontrib><creatorcontrib>Singal, Amit G</creatorcontrib><creatorcontrib>Dai, Jianliang</creatorcontrib><creatorcontrib>Lubman, David M</creatorcontrib><creatorcontrib>Mechref, Yehia</creatorcontrib><title>PRM-MS Quantitative Analysis of Isomeric N -Glycopeptides Derived from Human Serum Haptoglobin of Patients with Cirrhosis and Hepatocellular Carcinoma</title><title>Metabolites</title><addtitle>Metabolites</addtitle><description>Currently, surveillance strategies have inadequate performance for cirrhosis and early detection of hepatocellular carcinoma (HCC). The glycosylation of serum haptoglobin has shown to have significant differences between cirrhosis and HCC, thus can be used for diagnosis. We performed a comprehensive liquid chromatography-parallel reaction monitoring-mass spectrometry (LC-PRM-MS) approach, where a targeted parallel reaction monitoring (PRM) strategy was coupled to a powerful LC system, to study the site-specific isomerism of haptoglobin (Hp) extracted from cirrhosis and HCC patients. We found that our strategy was able to identify a large number of isomeric
-glycopeptides, mainly located in the Hp glycosylation site Asn207. Four
-glycopeptides were found to have significant changes in abundance between cirrhosis and HCC samples (
< 0.05). Strategic combinations of the significant
-glycopeptides, either with alpha-fetoprotein (AFP) or themselves, better estimate the areas under the curve (AUC) of their respective receiver operating characteristic (ROC) curves with respect to AFP. The combination of AFP with the isomeric sialylated fucosylated
-glycopeptides Asn207 + 5-6-1-2 and Asn207 + 5-6-1-3, resulted with an AUC value of 0.98, while the AUC value for AFP alone was 0.85. When comparing cirrhosis vs. early HCC, the isomeric
-glycopeptide Asn207 + 5-6-0-1 better estimated AUC with respect to AFP (AUC
= 0.81, and AUC
+ 5-6-0-1 = 0.88, respectively).</description><subject>Antibiotics</subject><subject>Cirrhosis</subject><subject>Glycopeptides</subject><subject>Glycosylation</subject><subject>Haptoglobin</subject><subject>Hepatocellular carcinoma</subject><subject>hepatocellular carcinoma (HCC)</subject><subject>Liquid chromatography</subject><subject>Liver cancer</subject><subject>Liver cirrhosis</subject><subject>Mass spectroscopy</subject><subject>N-glycopeptides</subject><subject>Patients</subject><subject>Peptides</subject><subject>PRM</subject><subject>Quantitative analysis</subject><subject>Retention</subject><subject>Ultrasonic imaging</subject><subject>α-Fetoprotein</subject><issn>2218-1989</issn><issn>2218-1989</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkkFv0zAUgCMEYtPYlSOyxIVLhh07jnNBmgqslTYYDM7Wi_3SukriYjtF_SP8XtJ1TCu--On586f37Jdlrxm94Lym73tM0HjGqKKl5M-y06JgKme1qp8_iU-y8xjXdFqSlhVlL7MTLgSXJRWn2Z_b7zf5zR35NsKQXILktkguB-h20UXiW7KIvsfgDPlC8qtuZ_wGN8lZjOTjlN6iJW3wPZmPPQzkDsM4xbBJftn5xg17w-0kxSFF8tulFZm5EFZ-L4fBkjluIHmDXTd2EMgMgnGD7-FV9qKFLuL5w36W_fz86cdsnl9_vVrMLq9zI5RIOefGmKKsFCK1UiFQRAGGWkGxBMEbZkExkFyYilkrWiir2iolKbayUDU_yxYHr_Ww1pvgegg77cHp-4QPSw0hOdOhZqCUEMKWnJYCJatbtC0waBpaNA3nk-vDwbUZmx6tmXoO0B1Jj08Gt9JLv9VKUFopOgnePQiC_zViTLp3cf82MKAfoy5KKWohOZUT-vY_dO3HMH3bPVXyWlBWTdTFgTLBxxiwfSyGUb2fIH08QdOFN09beMT_zQv_C6qBxQo</recordid><startdate>20210823</startdate><enddate>20210823</enddate><creator>Gutierrez Reyes, Cristian D</creator><creator>Huang, Yifan</creator><creator>Atashi, Mojgan</creator><creator>Zhang, Jie</creator><creator>Zhu, Jianhui</creator><creator>Liu, Suyu</creator><creator>Parikh, Neehar D</creator><creator>Singal, Amit G</creator><creator>Dai, Jianliang</creator><creator>Lubman, David M</creator><creator>Mechref, Yehia</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QR</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-5229-4723</orcidid><orcidid>https://orcid.org/0000-0002-6661-6073</orcidid></search><sort><creationdate>20210823</creationdate><title>PRM-MS Quantitative Analysis of Isomeric N -Glycopeptides Derived from Human Serum Haptoglobin of Patients with Cirrhosis and Hepatocellular Carcinoma</title><author>Gutierrez Reyes, Cristian D ; Huang, Yifan ; Atashi, Mojgan ; Zhang, Jie ; Zhu, Jianhui ; Liu, Suyu ; Parikh, Neehar D ; Singal, Amit G ; Dai, Jianliang ; Lubman, David M ; Mechref, Yehia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c484t-33ccc2578ee0d68ea0ee4ac0d40e5a43b1da81a634c71dd4fa579d8860ef62893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Antibiotics</topic><topic>Cirrhosis</topic><topic>Glycopeptides</topic><topic>Glycosylation</topic><topic>Haptoglobin</topic><topic>Hepatocellular carcinoma</topic><topic>hepatocellular carcinoma (HCC)</topic><topic>Liquid chromatography</topic><topic>Liver cancer</topic><topic>Liver cirrhosis</topic><topic>Mass spectroscopy</topic><topic>N-glycopeptides</topic><topic>Patients</topic><topic>Peptides</topic><topic>PRM</topic><topic>Quantitative analysis</topic><topic>Retention</topic><topic>Ultrasonic imaging</topic><topic>α-Fetoprotein</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gutierrez Reyes, Cristian D</creatorcontrib><creatorcontrib>Huang, Yifan</creatorcontrib><creatorcontrib>Atashi, Mojgan</creatorcontrib><creatorcontrib>Zhang, Jie</creatorcontrib><creatorcontrib>Zhu, Jianhui</creatorcontrib><creatorcontrib>Liu, Suyu</creatorcontrib><creatorcontrib>Parikh, Neehar D</creatorcontrib><creatorcontrib>Singal, Amit G</creatorcontrib><creatorcontrib>Dai, Jianliang</creatorcontrib><creatorcontrib>Lubman, David M</creatorcontrib><creatorcontrib>Mechref, Yehia</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Chemoreception Abstracts</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Metabolites</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gutierrez Reyes, Cristian D</au><au>Huang, Yifan</au><au>Atashi, Mojgan</au><au>Zhang, Jie</au><au>Zhu, Jianhui</au><au>Liu, Suyu</au><au>Parikh, Neehar D</au><au>Singal, Amit G</au><au>Dai, Jianliang</au><au>Lubman, David M</au><au>Mechref, Yehia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PRM-MS Quantitative Analysis of Isomeric N -Glycopeptides Derived from Human Serum Haptoglobin of Patients with Cirrhosis and Hepatocellular Carcinoma</atitle><jtitle>Metabolites</jtitle><addtitle>Metabolites</addtitle><date>2021-08-23</date><risdate>2021</risdate><volume>11</volume><issue>8</issue><spage>563</spage><pages>563-</pages><issn>2218-1989</issn><eissn>2218-1989</eissn><abstract>Currently, surveillance strategies have inadequate performance for cirrhosis and early detection of hepatocellular carcinoma (HCC). The glycosylation of serum haptoglobin has shown to have significant differences between cirrhosis and HCC, thus can be used for diagnosis. We performed a comprehensive liquid chromatography-parallel reaction monitoring-mass spectrometry (LC-PRM-MS) approach, where a targeted parallel reaction monitoring (PRM) strategy was coupled to a powerful LC system, to study the site-specific isomerism of haptoglobin (Hp) extracted from cirrhosis and HCC patients. We found that our strategy was able to identify a large number of isomeric
-glycopeptides, mainly located in the Hp glycosylation site Asn207. Four
-glycopeptides were found to have significant changes in abundance between cirrhosis and HCC samples (
< 0.05). Strategic combinations of the significant
-glycopeptides, either with alpha-fetoprotein (AFP) or themselves, better estimate the areas under the curve (AUC) of their respective receiver operating characteristic (ROC) curves with respect to AFP. The combination of AFP with the isomeric sialylated fucosylated
-glycopeptides Asn207 + 5-6-1-2 and Asn207 + 5-6-1-3, resulted with an AUC value of 0.98, while the AUC value for AFP alone was 0.85. When comparing cirrhosis vs. early HCC, the isomeric
-glycopeptide Asn207 + 5-6-0-1 better estimated AUC with respect to AFP (AUC
= 0.81, and AUC
+ 5-6-0-1 = 0.88, respectively).</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>34436504</pmid><doi>10.3390/metabo11080563</doi><orcidid>https://orcid.org/0000-0001-5229-4723</orcidid><orcidid>https://orcid.org/0000-0002-6661-6073</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2218-1989 |
ispartof | Metabolites, 2021-08, Vol.11 (8), p.563 |
issn | 2218-1989 2218-1989 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_1a88444d53054e619fedfa1abb02bb33 |
source | PubMed Central (Open Access); Publicly Available Content Database (Proquest) (PQ_SDU_P3) |
subjects | Antibiotics Cirrhosis Glycopeptides Glycosylation Haptoglobin Hepatocellular carcinoma hepatocellular carcinoma (HCC) Liquid chromatography Liver cancer Liver cirrhosis Mass spectroscopy N-glycopeptides Patients Peptides PRM Quantitative analysis Retention Ultrasonic imaging α-Fetoprotein |
title | PRM-MS Quantitative Analysis of Isomeric N -Glycopeptides Derived from Human Serum Haptoglobin of Patients with Cirrhosis and Hepatocellular Carcinoma |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T10%3A45%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PRM-MS%20Quantitative%20Analysis%20of%20Isomeric%20N%20-Glycopeptides%20Derived%20from%20Human%20Serum%20Haptoglobin%20of%20Patients%20with%20Cirrhosis%20and%20Hepatocellular%20Carcinoma&rft.jtitle=Metabolites&rft.au=Gutierrez%20Reyes,%20Cristian%20D&rft.date=2021-08-23&rft.volume=11&rft.issue=8&rft.spage=563&rft.pages=563-&rft.issn=2218-1989&rft.eissn=2218-1989&rft_id=info:doi/10.3390/metabo11080563&rft_dat=%3Cproquest_doaj_%3E2565394017%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c484t-33ccc2578ee0d68ea0ee4ac0d40e5a43b1da81a634c71dd4fa579d8860ef62893%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2565394017&rft_id=info:pmid/34436504&rfr_iscdi=true |